BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cohen S, Ifergane G, Vainer E, Matar MA, Kaplan Z, Zohar J, Mathé AA, Cohen H. The wake-promoting drug modafinil stimulates specific hypothalamic circuits to promote adaptive stress responses in an animal model of PTSD. Transl Psychiatry 2016;6:e917. [PMID: 27727245 DOI: 10.1038/tp.2016.172] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Cohen S, Matar MA, Vainer E, Zohar J, Kaplan Z, Cohen H. Significance of the orexinergic system in modulating stress-related responses in an animal model of post-traumatic stress disorder. Transl Psychiatry 2020;10:10. [PMID: 32066707 DOI: 10.1038/s41398-020-0698-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
2 Stone LA, Girgenti MJ, Wang J, Ji D, Zhao H, Krystal JH, Duman RS. Cortical Transcriptomic Alterations in Association With Appetitive Neuropeptides and Body Mass Index in Posttraumatic Stress Disorder. Int J Neuropsychopharmacol 2021;24:118-29. [PMID: 32951025 DOI: 10.1093/ijnp/pyaa072] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Nevárez N, de Lecea L. Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation. F1000Res 2018;7:F1000 Faculty Rev-1421. [PMID: 30254737 DOI: 10.12688/f1000research.15097.1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
4 Malikowska-Racia N, Sałat K, Nowaczyk A, Fijałkowski Ł, Popik P. Dopamine D2/D3 receptor agonists attenuate PTSD-like symptoms in mice exposed to single prolonged stress. Neuropharmacology 2019;155:1-9. [PMID: 31085186 DOI: 10.1016/j.neuropharm.2019.05.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
5 Seigneur E, de Lecea L. Hypocretin (Orexin) Replacement Therapies. Medicine in Drug Discovery 2020;8:100070. [DOI: 10.1016/j.medidd.2020.100070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nwokafor C, Serova LI, Sabban EL. Preclinical findings on the potential of intranasal neuropeptide Y for treating hyperarousal features of PTSD. Ann N Y Acad Sci 2019;1455:149-59. [PMID: 31250475 DOI: 10.1111/nyas.14172] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wilson MA, Liberzon I, Lindsey ML, Lokshina Y, Risbrough VB, Sah R, Wood SK, Williamson JB, Spinale FG. Common pathways and communication between the brain and heart: connecting post-traumatic stress disorder and heart failure. Stress 2019;22:530-47. [PMID: 31161843 DOI: 10.1080/10253890.2019.1621283] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
8 Cohen H, Zohar J, Kaplan Z, Arnt J. Adjunctive treatment with brexpiprazole and escitalopram reduces behavioral stress responses and increase hypothalamic NPY immunoreactivity in a rat model of PTSD-like symptoms. Eur Neuropsychopharmacol 2018;28:63-74. [PMID: 29224968 DOI: 10.1016/j.euroneuro.2017.11.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
9 Ney LJ, Akhurst J, Bruno R, Laing PA, Matthews A, Felmingham KL. Dopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSD. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2021;105:110118. [DOI: 10.1016/j.pnpbp.2020.110118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]